
    
      This study is designed to evaluate if the FDC tablet of 5 mg saxagliptin/1000 mg metformin
      extended release (manufactured in Mt Vernon, Indiana) is bioequivalent to the coadministered
      5 mg saxagliptin tablet plus 2 x 500 mg Glucophage XR tablets (manufactured in Evansville,
      Indiana)
    
  